{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:19:17Z","timestamp":1790439557289,"version":"4.1.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2019.00044","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:34:01Z","timestamp":1552624441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Unraveling Tumor Heterogeneity in an Apparently Monolithic Disease: BCL2 and Other Players in the Genetic Landscape of Nodal Follicular Lymphoma"],"prefix":"10.3389","volume":"6","author":[{"given":"Francesca","family":"Magnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Tibiletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Swerdlow","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/PAT.0b013e3283513fb2","article-title":"Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations","volume":"44","author":"Masir","year":"2012","journal-title":"Pathology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.humpath.2013.02.004","article-title":"The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-\u201cnegative\u201d grade 1\/2 follicular lymphomas","volume":"44","author":"Adam","year":"2013","journal-title":"Hum Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of Follicular Lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis","volume":"203","author":"Roulland","year":"2006","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals","volume":"124","author":"Sch\u00fcler","year":"2009","journal-title":"Int J Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3389\/fimmu.2017.00912","article-title":"Altered N-linked glycosylation in follicular lymphoma and chronic lymphocytic leukemia: involvement in pathogenesis and potential therapeutic targeting","volume":"8","author":"Hollander","year":"2017","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Hematologica."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/leu.2011.266","article-title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","volume":"26","author":"Launay","year":"2012","journal-title":"Leukemia."},{"key":"B18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Hematologica."},{"key":"B19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study","volume":"33","author":"Casulo","year":"2015","journal-title":"J Clin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-015-2303-5","article-title":"Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis","volume":"94","author":"Lerch","year":"2015","journal-title":"Ann Hematol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)","volume":"126","author":"Wagner-Johnston","year":"2015","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1182\/blood-2010-03-272278","article-title":"Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones","volume":"116","author":"Eide","year":"2010","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/s41375-018-0043-y","article-title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","volume":"32","author":"Araf","year":"2018","journal-title":"Leukemia."},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2016.08.028","article-title":"Clonal cooperativity in heterogenous cancers","volume":"64","author":"Zhou","year":"2017","journal-title":"Semin Cell Dev Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/bcj.2014.67","article-title":"Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma","volume":"4","author":"Barreca","year":"2014","journal-title":"Blood Cancer J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.cell.2014.11.013","article-title":"B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity","volume":"159","author":"Qian","year":"2014","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.cell.2013.11.039","article-title":"Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation","volume":"155","author":"Kieffer-Kwon","year":"2013","journal-title":"Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature."},{"key":"B35","unstructured":"Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma14059\n            RossiD\n            BerraE\n            CerriM\n            DeambrogiC\n            BarbieriC\n            FranceschettiS\n          17018394Haematologica.912006"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3109\/10428194.2013.769218","article-title":"Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma","volume":"54","author":"Kim","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"B37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/modpathol.2016.214","article-title":"Epstein-Barr virus-positive follicular lymphoma","volume":"30","author":"Mackrides","year":"2017","journal-title":"Mod Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"E62","DOI":"10.1002\/ajh.25357","article-title":"Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma","volume":"94","author":"Mackrides","year":"2019","journal-title":"Am J Hematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/cas.12442","article-title":"Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis","volume":"105","author":"Suguro","year":"2014","journal-title":"Cancer Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.4049\/jimmunol.1401699","article-title":"Intraclonal diversity in follicular lymphoma analyzed by quantitative ultra-deep sequencing of non-coding regions","volume":"193","author":"Spence","year":"2014","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","article-title":"Pathogenesis, diagnosis, and treatment of composite lymphomas","volume":"15","author":"K\u00fcppers","year":"2014","journal-title":"Lancet Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.56.1","article-title":"Follicular lymphoma: the role of the tumor microenvironment in prognosis","volume":"56","author":"Sugimoto","year":"2016","journal-title":"J Clin Exp Hematop."},{"key":"B49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer."},{"key":"B50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.leu.2402739","article-title":"Is t(14;18)(q32;q21) a constant finding in follicular lymphoma?","volume":"17","author":"Godon","year":"2003","journal-title":"Leukemia."},{"key":"B51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cancergencyto.2004.05.012","article-title":"Variant t(14;18) in malignant lymphoma: a report of seven cases","volume":"157","author":"Bentley","year":"2005","journal-title":"Cancer Genet Cytogenet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1182\/blood.V99.12.4265","article-title":"Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation","volume":"99","author":"Biagi","year":"2002","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2141.1990.tb07836.x","article-title":"The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction","volume":"76","author":"Pezzella","year":"1990","journal-title":"Br J Haematol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.humpath.2008.06.032","article-title":"BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome","volume":"40","author":"Tibiletti","year":"2009","journal-title":"Hum Pathol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","article-title":"Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances","volume":"19","author":"Guo","year":"2005","journal-title":"Leukemia."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/his.12119","article-title":"Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours","volume":"63","author":"Chang","year":"2013","journal-title":"Histopathology."},{"key":"B57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00051298","article-title":"The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants","volume":"7","author":"Herrinton","year":"1996","journal-title":"Cancer Causes Control."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1182\/blood.V101.3.1149","article-title":"Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive","volume":"101","author":"Bosga-Bouwer","year":"2003","journal-title":"Blood."},{"key":"B60","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br J Haematol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica."},{"key":"B62","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood."},{"key":"B63","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","article-title":"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype","volume":"118","author":"Leich","year":"2011","journal-title":"Blood."},{"key":"B64","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.onc.1206152","article-title":"Ambivalent role of BCL6 in cell survival and transformation","volume":"22","author":"Albagli-Curiel","year":"2003","journal-title":"Oncogene."},{"key":"B65","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ccr.2007.08.011","article-title":"A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma","volume":"12","author":"Saito","year":"2007","journal-title":"Cancer Cell."},{"key":"B66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"Am J Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/his.12076","article-title":"Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups","volume":"62","author":"Marafioti","year":"2013","journal-title":"Histopathology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/modpathol.2008.75","article-title":"BCL6 gene amplification\/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood.V99.2.409","article-title":"Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry","volume":"99","author":"Falini","year":"2002","journal-title":"Blood."},{"key":"B70","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/labinvest.3700051","article-title":"Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray","volume":"84","author":"Zha","year":"2004","journal-title":"Lab Invest."},{"key":"B72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1440-1827.2006.02072.x","article-title":"Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and\/or Bcl6 or p53 expression","volume":"57","author":"Guo","year":"2007","journal-title":"Pathol Int."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3324\/haematol.13239","article-title":"Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression","volume":"93","author":"Gagyi","year":"2008","journal-title":"Haematologica."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00044\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:34:10Z","timestamp":1552624450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00044\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":75,"alternative-id":["10.3389\/fmed.2019.00044"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2019.00044","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"article-number":"44"}}